Zogenix (ZGNX) On Watch After FDA Briefing Docs Posted
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall St futures slip as chip stocks drag; Netflix tumbles
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Goldman sees central bank demand providing a floor for gold prices
- Alphabet stock falls on report of Gemini AI model delays
- Nike out of World Cup contention as Adidas-outfitted teams head to final
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
Zogenix (ZGNX) Zohydro ER Fails to Win FDA Panel Backing
December 7, 2012 4:38 PM ESTZogenix (Nasdaq: ZGNX) Zohydro ER fails to win FDA panel backing.... More
Zogenix's (ZGNX) Zohydro Unsafe to Treat Intended Patients, FDA Panel Says
December 7, 2012 3:29 PM ESTThe FDA panel now says that Zogenix's (NASDAQ: ZGNX) Zohydro is unsafe for intended patients. The panel voted 9 - 5 that the painkiller is unsafe.... More
FDA Panel Says Zogenix (ZGNX) Zohydro ER Effective to Treat Pain
December 7, 2012 2:54 PM ESTZogenix (NASDAQ: ZGNX) Zohydro ER effective to treat pain, FDA says. The vote was tight at 7 - 6.... More
Zogenix (ZGNX) Halted Ahead of FDA Committee Meeting for Zohydro ER NDA
December 7, 2012 7:02 AM ESTZogenix, Inc. (Nasdaq: ZGNX) announced that NASDAQ halted trading of the company's common stock on December 7, 2012. The U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is meeting today to review the Company's New Drug Application (NDA) for Zohydro ER (hydrocodone bitartrate extended-release capsules).... More
